124 related articles for article (PubMed ID: 8785473)
1. The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Farrell CL; Bready JV; Kaufman SA; Qian YX; Burgess TL
Antisense Res Dev; 1995; 5(3):175-83. PubMed ID: 8785473
[TBL] [Abstract][Full Text] [Related]
2. Sequence dependency of the internalization and distribution of phosphorothioate oligonucleotides in vascular smooth muscle cells.
Etore F; Tenu JP; Teiger E; Adnot S; Lonchampt MO; Pirotzki E; Le Doan T
Biochem Pharmacol; 1998 May; 55(9):1465-73. PubMed ID: 10076539
[TBL] [Abstract][Full Text] [Related]
3. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
Pickering JG; Isner JM; Ford CM; Weir L; Lazarovits A; Rocnik EF; Chow LH
Circulation; 1996 Feb; 93(4):772-80. PubMed ID: 8641007
[TBL] [Abstract][Full Text] [Related]
4. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
5. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
[TBL] [Abstract][Full Text] [Related]
6. Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries.
Kume M; Komori K; Matsumoto T; Onohara T; Takeuchi K; Yonemitsu Y; Sugimachi K
Circulation; 2002 Mar; 105(10):1226-32. PubMed ID: 11889018
[TBL] [Abstract][Full Text] [Related]
7. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
Santiago FS; Atkins DG; Khachigian LM
Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
[TBL] [Abstract][Full Text] [Related]
9. Use of a simple fractionation method to evaluate binding, internalization and intracellular distribution of oligonucleotides in vascular smooth muscle cells.
Eboue D; Auger R; Angiari C; Le Doan T; Tenu JP
Arch Physiol Biochem; 2003 Jul; 111(3):265-72. PubMed ID: 14972750
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells.
Lövdahl C; Thyberg J; Cercek B; Blomgren K; Dimayuga P; Kallin B; Hultgårdh-Nilsson A
Histol Histopathol; 1999 Oct; 14(4):1101-12. PubMed ID: 10506926
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
12. Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake.
Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J
Antisense Res Dev; 1995; 5(3):193-201. PubMed ID: 8785475
[TBL] [Abstract][Full Text] [Related]
13. Local delivery of c-myb antisense oligonucleotides during balloon angioplasty.
Azrin MA; Mitchel JF; Bow LM; Pedersen CA; Cartun RW; Aretz TH; Waters DD; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):232-40. PubMed ID: 9213020
[TBL] [Abstract][Full Text] [Related]
14. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
[TBL] [Abstract][Full Text] [Related]
15. The effect of locally delivered c-myc antisense oligonucleotides combined with intravascular brachytherapy of 188Re liquid-filled balloon therapy on vascular smooth muscle cell proliferation in rabbit iliac arteries after injury with a balloon catheter.
Wang W; Li JL; Wang X
Biochem Cell Biol; 2007 Apr; 85(2):164-8. PubMed ID: 17534395
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phenotype modulation, growth, and migration of vascular smooth muscle cells by a guanosine-rich 30-mer phosphorothioate oligodeoxynucleotide.
Graham LD; Hayward IP; Fitzgerald M; Whitelock JM; Bingley JA; Campbell JH; Underwood PA
Cell Biol Int; 1997 Sep; 21(9):585-94. PubMed ID: 9570893
[TBL] [Abstract][Full Text] [Related]
17. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336
[TBL] [Abstract][Full Text] [Related]
18. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
Wingens M; van Hooijdonk CA; de Jongh GJ; Schalkwijk J; van Erp PE
Arch Dermatol Res; 1998 Mar; 290(3):119-25. PubMed ID: 9558486
[TBL] [Abstract][Full Text] [Related]
20. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.
Simons M; Edelman ER; Rosenberg RD
J Clin Invest; 1994 Jun; 93(6):2351-6. PubMed ID: 7911126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
